November 2025
40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC 2025) National Harbor, MD
- “ATF6 activation promotes ICB response in melanoma”, Brian Koss
- “Proteome turnover dynamics analysis uncovers E3 ligases that enhance T cell persistence during exhaustion”, Sydnye Shuttleworth
- "Engineering EZH2-Inhibitor Resistant CAR-T Cells to Preserve Function for Combination Therapy”, Daniel Fil
- "Donor-intrinsic Proteomic Programs Shape CAR-T Cell Persistence Across a Longitudinal Killing Assay”, Katie Cruse
- "Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response”, Jessica Kelliher
- CD28 Co-stimulation Induces PCK2 to Support T Cell Effector Function in Metabolically Hostile Environments”, Thomas Williams
